Christopher Gibson - Mar 6, 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Signature
/s/ Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Mar 6, 2024
Transactions value $
-$543,121
Form type
4
Date filed
3/8/2024, 07:08 PM
Previous filing
Feb 16, 2024
Next filing
Apr 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Conversion of derivative security $0 +10K +0.91% $0.00 1.11M Mar 6, 2024 Direct F1, F2
transaction RXRX Class A Common Stock Gift $0 -10K -0.9% $0.00 1.1M Mar 6, 2024 Direct F1
transaction RXRX Class A Common Stock Options Exercise $77.5K +31.3K +2.83% $2.48 1.14M Mar 6, 2024 Direct F1
transaction RXRX Class A Common Stock Options Exercise $98.9K +8.67K +0.76% $11.40 1.14M Mar 6, 2024 Direct F1
transaction RXRX Class A Common Stock Sale -$431K -36.3K -3.17% $11.86 1.11M Mar 6, 2024 Direct F1, F3
transaction RXRX Class A Common Stock Conversion of derivative security $0 +4K $0.00 4K Mar 6, 2024 by LAHWRAN-3 LLC F1, F4, F5
transaction RXRX Class A Common Stock Sale -$46.3K -4K -100% $11.56 0 Mar 6, 2024 by LAHWRAN-3 LLC F1, F5, F6
transaction RXRX Class A Common Stock Conversion of derivative security $0 +20K $0.00 20K Mar 6, 2024 By LAHWRAN-4 LLC F1, F4, F7
transaction RXRX Class A Common Stock Sale -$231K -20K -100% $11.55 0 Mar 6, 2024 By LAHWRAN-4 LLC F1, F7, F8
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1K $0.00 1K Mar 6, 2024 by Gibson Family Trust F1, F4, F9
transaction RXRX Class A Common Stock Sale -$11.6K -1K -100% $11.56 0 Mar 6, 2024 by Gibson Family Trust F1, F9, F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -31.3K -9.09% $0.00 313K Mar 6, 2024 Class A Common Stock 31.3K $2.48 Direct F1, F11
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -8.67K -2.13% $0.00 399K Mar 6, 2024 Class A Common Stock 8.67K $11.40 Direct F1, F12
transaction RXRX Class B Common Stock Conversion of derivative security $0 -10K -0.15% $0.00 6.46M Mar 6, 2024 Class A Common Stock 10K $0.00 Direct F1, F2, F13
transaction RXRX Class B Common Stock Conversion of derivative security $0 -4K -0.78% $0.00 511K Mar 6, 2024 Class A Common Stock 4K $0.00 by LAHWRAN-3 LLC F1, F4, F5, F13
transaction RXRX Class B Common Stock Conversion of derivative security $0 -20K -4.9% $0.00 388K Mar 6, 2024 Class A Common Stock 20K $0.00 by LAHWRAN-4 LLC F1, F4, F7, F13
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1K -0.84% $0.00 118K Mar 6, 2024 Class A Common Stock 1K $0.00 by Gibson Family Trust F1, F4, F9, F13
holding RXRX Stock Option (Right to Buy) 814K Mar 6, 2024 Class A Common Stock 0 $8.55 Direct F14
holding RXRX Stock Option (Right to Buy) 5.44K Mar 6, 2024 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 667K Mar 6, 2024 Class A Common Stock 0 $10.09 Direct F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2022.
F2 Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person.
F3 This transaction was executed in multiple trades at prices ranging from $11.24 to $12.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 Represents the conversion of Class B Common Stock into Class A Common Stock.
F5 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F6 This transaction was executed in multiple trades at prices ranging from $11.32 to $12.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F8 This transaction was executed in multiple trades at prices ranging from $11.22 to $12.09. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
F10 This transaction was executed in multiple trades at prices ranging from $11.23 to $12.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F11 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F12 The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F13 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F14 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F15 The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.